Global Animal Vaccines Market
Overview:
Vaccine is a biological substance that stimulates the immune responses of the body against various diseases and improves health and increases life expectancy. Veterinary vaccines impact the animal’s health and their production quality. These also help in maintaining good health of human population as we consume various food products obtained from animals. Diseases like hepatitis rotavirus, rabies, pinkeye, brucellosis, E. coli, parvovirus and distemper can be treated using veterinary vaccines. Vaccines can be classified into toxoid vaccines, subunit and DNA vaccines, conjugated vaccines, inactivated vaccines and live attenuated vaccines.
Impact of COVID-19:
The rapid spread of COVID-19 across the globe is posing a challenge for veterinary healthcare systems worldwide. Transmission of COVID-19 has been a high challenge for the veterinary healthcare system globally. The Centers for Disease Control & Protection published their data in November 2021, mentioning that the risk of animals transmitting COVID-19, by the SARS-CoV-2 is low, as there is no evidence to prove the role of animals in spreading the virus. Owning to the strict lockdown measures veterinary visits were carried out through video calls from mobile phones and tablets. For instance, Boehringer Ingelheim U.K. partner up with VetHelpDirect in April 2020, for providing free access to online video consultation platform for three months during the pandemic. This would help in taking care of animals as well as protecting the staff and the patients from COVID-19.
Veterinary research centers are focusing on manufacturing a COVID-19 vaccine for animals. For instance, in June 2020, the Indian Veterinary Research Institute declared their proposal for developing diagnostic kits and a vaccine and also studying the advances of transmission of COVID-19 in wild animals and pets. This project will be conducted in partnership with IIT-Roorkee, India.
To Get More Business Strategies Copy of This Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/4989
Moreover, rise in demand for vaccinations for animals is expected to enhance the growth of the global animal vaccines market during the forecast period.
The global animal vaccines market is expected to be valued at US$ 7,119.7 Million in 2021, and is anticipated to exhibit a CAGR of 6.6% during the forecast period.
Drivers:
Rise in research and development activities is anticipated to propel the growth of the global animal vaccines market during the forecast period. These projects will help in understanding viral diseases, and discover vaccinations for protecting animals against various diseases. For instance, Regeneron Pharmaceuticals, Inc. has declared a five-year collaboration in June 2018, for studying the use of Regeneron’s monoclonal antibody therapeutics in animals and help in finding veterinary treatments.
Furthermore, key players are focusing on launching generic versions of opioid medications which is estimated to boost the growth of the global animal vaccines market during the forecast period. For instance, a division of Merck & Co., Inc., MSD Animal Health, launched NOBIVAC Myxo-RHD PLUS vaccine for reducing the clinical signs and mortality rate of myxomatosis and rabbit haemorrhagic disease, these are most common viral diseases in rabbits. Both these diseases are caused by RHDV1 and its variant strain RHDV2.
Restraints:
Storage and handling of vaccines is an important factor in preventing and eradicating common vaccine-preventable diseases. Every year several animals have to be revaccinated due to handling and storage errors and this leads to financial loss, reduction in potency of vaccines, impoverished vaccine responses and poor protection against diseases.
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables& Figures, Chart) @ https://www.coherentmarketinsights.com/insight/request-pdf/4989
Regional Analysis:
North America is expected to witness robust growth in the global animal vaccines market over the forecast period due to rise in initiatives taken by government as well as private organizations related to animal vaccination. For instance, in January 2020, the Animal and Plant Health Inspection Service from the U.S. Department of Agriculture declare that will be rewarding US$ 10.2 million for supporting emergency response training, prevention of diseases and for developing Veterinary Countermeasures Bank and the National Animal Vaccine.
Market Taxonomy:
By Product Type:
- Attenuated Live Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
By Application:
- Companion Animal
- Livestock Animal
- Poultry
- Aquaculture
By Distribution Channel:
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Others
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Key Players:
Key players active in the global animal vaccines market are Biogénesis Bagó, Merck & Co. Inc., Vaxxinova In ternational BV, Boehringer Ingelheim International GmbH., Biovac, Zoetis Inc., Romvac Company Sa, Elanco Animal Health Incorporated, HIPRA and Ceva.
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/4989
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Animal Vaccines Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Animal Vaccines Market Industry Impact
Chapter 2 Animal Vaccines Market Competition by Types, Applications, and Top Regions and Countries
2.1 Animal Vaccines Market (Volume and Value) by Type
2.3 Animal Vaccines Market (Volume and Value) by Regions
Chapter 3 Animal Vaccines Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Animal Vaccines Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Automotive Adaptive Front Lighting Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Animal Vaccines Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Trading Analysis
8.1 Export of Automotive Adaptive Front Lighting by Region
8.2 Import of Automotive Adaptive Front Lighting by Region
8.3 Balance of Trade
Chapter 9 Historical and Current Animal Vaccines in North America (2016-2021)
9.1 Animal Vaccines Supply
9.2 Animal Vaccines Demand by End Use
9.3 Competition by Players/Suppliers
9.4 Type Segmentation and Price
9.5 Key Countries Analysis
9.5.1 US
9.5.2 Canada
9.5.3 Mexico
Chapter 10 Company Profiles and Key Figures in Animal Vaccines Market Business
Chapter 11 Animal Vaccines Market Forecast (2021-2028)
Chapter 12 Conclusions
Research Methodology….
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837